COL17A1 and junctional epidermolysis bullosa: This theory is proven in patients with junctional epidermolysis bullosa (JEB), a disorder characterized by mutations in the COL17A1 gene resulting in the absence of collagen XVII or expression of a structurally altered protein leading to subepidermal blistering and immature HDs (44, 46–48).